Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,252,000 | 2,841,000 | 3,832,000 | 4,184,000 | 3,391,000 |
| Marketable Securities | 67,000 | 72,000 | 83,000 | 81,000 | 226,000 |
| Inventories | 4,167,000 | 4,143,000 | 4,197,000 | 3,969,000 | 4,036,000 |
| Other current assets | 5,986,000 | 6,380,000 | 6,005,000 | 5,457,000 | 5,840,000 |
| TOTAL | $13,472,000 | $13,436,000 | $14,117,000 | $13,692,000 | $13,493,000 |
| Non-Current Assets | |||||
| PPE Net | 8,766,000 | 8,973,000 | 9,147,000 | 8,776,000 | 8,585,000 |
| Intangibles | 14,181,000 | 14,775,000 | 14,906,000 | 14,520,000 | 13,182,000 |
| Other Non-Current Assets | 4,691,000 | 4,875,000 | 4,722,000 | 4,487,000 | 5,193,000 |
| TOTAL | $27,638,000 | $28,623,000 | $28,775,000 | $27,783,000 | $26,960,000 |
| Total Assets | $41,110,000 | $42,059,000 | $42,892,000 | $41,475,000 | $40,453,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 3,604,000 | N/A |
| Accounts payable and accrued liabilities | 7,795,000 | 7,836,000 | 7,713,000 | 2,666,000 | 7,683,000 |
| TOTAL | $12,832,000 | $12,477,000 | $12,008,000 | $13,815,000 | $13,964,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 14,622,000 | N/A |
| Other Non-Current Liabilities | 19,632,000 | 20,427,000 | 21,318,000 | 4,301,000 | 17,819,000 |
| TOTAL | $21,477,000 | $22,311,000 | $23,267,000 | $20,913,000 | $19,461,000 |
| Total Liabilities | $34,309,000 | $34,788,000 | $35,275,000 | $34,728,000 | $33,425,000 |
| Shareholders' Equity | |||||
| Common Shares | 1,341,000 | 1,353,000 | 1,352,000 | 1,349,000 | 1,361,000 |
| Retained earnings | -129,000 | 414,000 | 1,296,000 | 652,000 | 1,067,000 |
| Other shareholders' equity | 2,255,000 | 2,205,000 | 1,907,000 | 1,787,000 | 1,840,000 |
| TOTAL | $5,974,000 | $6,412,000 | $6,694,000 | $5,810,000 | $6,223,000 |
| Total Liabilities And Equity | $40,283,000 | $41,200,000 | $41,969,000 | $40,538,000 | $39,648,000 |